A single-center, randomized, double-blind, placebo-controlled Phase I clinical tolerance, pharmacokinetics and pharmacodynamics study of hypodermic injection of pegfilgrastin (PEG - G-CSF) with single doses in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2016
Price : $35 *
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Leucopenia
- Focus Pharmacodynamics; Pharmacokinetics
- 24 Sep 2016 Status changed from recruiting to completed.
- 02 Jul 2014 New trial record